Tumor Profiling Market Insights Highlight Segment Expansion And Market Leadership

The tumor profiling market is on the cusp of significant expansion, driven by advances in technology and a growing emphasis on personalized cancer care. As precision medicine continues to gain traction, this sector is expected to evolve rapidly, offering new opportunities and innovations that could transform cancer diagnosis and treatment. Let's explore the current market size, key players, emerging trends, and how the market is segmented for a comprehensive understanding.

Projected Growth Trajectory of the Tumor Profiling Market Size by 2030
The tumor profiling market is poised for robust growth, with its size forecasted to reach $17.96 billion by 2030. This reflects a strong compound annual growth rate (CAGR) of 9.9% throughout the forecast period. Key factors propelling this expansion include the broader adoption of precision oncology techniques, an increasing demand for tailored cancer therapies, technological breakthroughs in bioinformatics platforms, the growing presence of companion diagnostics, and heightened investment in translational cancer research. Notable trends shaping the market include widespread use of next-generation sequencing, the rise of multi-omics profiling strategies, greater integration of AI-driven data analysis, expansion of personalized oncology solutions, and intensified efforts in biomarker discovery.

The tumor profiling market size has grown rapidly in recent years. It will grow from $11.18 billion in 2025 to $12.31 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising cancer incidence rates, expansion of molecular diagnostics laboratories, increasing use of targeted cancer therapies, advancements in sequencing technologies, growth of oncology research funding.

Download a free sample of the tumor profiling market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Players Influencing the Tumor Profiling Market
Several leading companies have established a strong foothold in the tumor profiling industry. These include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., and Predictive Oncology Inc.
In a notable development from February 2024, Myriad Genetics Inc., a US-based leader in genetic testing and precision medicine, acquired assets from Intermountain Precision Genomics (IPG). This acquisition, for an undisclosed amount, enhances Myriad's precision oncology portfolio by incorporating IPG's precise tumor test, precise liquid test, and their CLIA-certified laboratory in St. George, Utah. IPG is renowned for its expertise in molecular diagnostics and tumor profiling, making this a strategic move to advance patient care.

Emerging Trends Shaping the Tumor Profiling Market Outlook
Industry leaders are increasingly focusing on creating cutting-edge solutions powered by artificial intelligence to boost the precision and efficiency of cancer diagnostics and treatments. AI employs sophisticated computational techniques to analyze complex genomic, proteomic, and clinical datasets, facilitating faster diagnoses, personalized therapies, and improved disease monitoring.
For example, in January 2025, Panakeia Technologies LTD, a UK-based firm specializing in AI-driven cancer diagnostic software, introduced PANProfiler Colon. This AI-based software is tailored to profile critical molecular biomarkers such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR) from H and E-stained images of colon cancer tissue. This innovative digital tool streamlines molecular tumor profiling, essential for diagnosing colorectal cancer, detecting Lynch syndrome cases, and guiding personalized treatment strategies.

View the full tumor profiling market report:
https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Detailed Segmentation of the Global Tumor Profiling Market
The tumor profiling market is broadly categorized based on different techniques, technologies, and applications. These segments provide a detailed view of the diverse approaches and tools used in this field.
1) By Technique: Genomics, Proteomics, Epigenetics, and Metabolomics
2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), and Microarray
3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, and Research

Further sub-classifications include:
- Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, and Sanger Sequencing
- Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), and Western Blotting
- Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, and Non-Coding RNA Analysis
- Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Capillary Electrophoresis-Mass Spectrometry (CE-MS)

This comprehensive segmentation highlights the complexity and innovation embedded in tumor profiling, underscoring its critical role in advancing personalized oncology.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.